Testing inflammation changes in people on ECMO
Part of Lungs & breathing clinical trials.
This study looks at inflammation during ECMO (a heart-lung bypass machine) and while people are being weaned off it. It may help doctors better understand which patients are improving safely during ECMO and when to reduce support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have severe lung distress from ARDS and are currently on venovenous ECMO (vvECMO)
- Your breathing and ventilator settings have been stable or improved in the last 24 hours (oxygen levels, lung flexibility, and tidal volume while on higher PEEP)
- Your blood pressure is steady enough for standard intensive care (hemodynamically stable)
- A doctor can get consent from you or your legal representative
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares starting ECMO early versus later in adults with severe lung failure (ARDS). It tests whether starting the life-support machine sooner can improve outcomes by the time doctors need it.
This trial studies whether a change in how a veno-venous ECMO machine works can reduce “blood recirculation” (blood returning to the circuit too quickly) in people with severe lung failure. It may help improve oxygen levels in adults whose ARDS is not responding to standard treatment.
This trial is for people with severe lung failure (ARDS) who are already on a life-support machine called VV-ECMO. It tests whether adding a special breathing tube (CPAP) can help their lungs heal better.
This trial looks at how changes in lung pressure during breathing might affect recovery in patients with severe ARDS who are on a heart-lung bypass machine (ECMO). It could help doctors improve treatment for people with this serious lung condition.
This trial tests a full-course strategy using a heart-lung bypass machine (ECMO) for people with moderate-to-severe acute respiratory distress syndrome (ARDS), a serious lung condition. The goal is to see if starting and continuing ECMO throughout treatment improves recovery.
This study looks at how blood cells called platelets change in people who are on a heart-lung machine (ECMO) in the ICU. It aims to better understand how the body responds to this support.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.